Release Date: 29/04/11 11:01 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 20.45KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%